1型神经纤维细胞瘤患者的肝细胞瘤:一个病例报告
A Praga1, T Z Hirsch2, D Vidaud3
1Centre de Recherche des Cordeliers, Université Paris Cité, Sorbonne Université, Inserm, F-75006, Paris, France.
Cancer genetics
|January 25, 2025
概括
这项研究报告了Neurofibromatosis type 1 (NF1) 患者肝细胞母细胞瘤的第三例病例. 研究人员讨论了这种罕见的肝癌与遗传性疾病NF1.1之间的潜在联系.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 皮肤病学 皮肤病学
背景情况:
- 神经纤维素瘤类型1 (NF1) 是一种常见的基因皮肤病,影响多个器官.
- NF1增加了良性和恶性瘤的风险,主要是在神经系统和软组织.
- 肝母细胞瘤是NF1患者中异常罕见的瘤,之前只有两例病例被记录.
研究的目的:
- 报告第三个已记录的肝细胞瘤病例,该病例发生在NF1.1患者身上.
- 为了研究这种NF1患者肝母细胞瘤的遗传基础.
- 探索NF1和肝细胞瘤的发展之间的潜在联系.
主要方法:
- 一个11岁女孩的病例介绍,她患有NF1并被诊断为甲状腺肝母细胞瘤与转移.
- 通过针对性血液分析确定了生殖系NF1变异.
- 在瘤和转移样本上进行外基因组测序,RNA测序和甲基化分析.
主要成果:
- 在患者中确认了生殖线NF1变异.
- 在瘤样本中识别与肝细胞母细胞瘤相关的经典驱动变异.
- 患者的瘤显示出表皮性肝细胞母细胞瘤与肺转移的特征.
结论:
- 这一病例代表了NF1.1个体肝细胞瘤的第三例.
- 这些发现有助于理解NF1和肝细胞瘤之间的罕见关联.
- 需要进一步的研究来阐明NF1和这种特定的肝癌之间的潜在因果关系.
更多相关视频
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.5K
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
504
相关概念视频
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
